We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

75 hedge funds and large institutions have $136M invested in abrdn Life Sciences Investors in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 32 increasing their positions, 26 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 26

8% more capital invested

Capital invested by funds: $126M → $136M (+$10.4M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.09% less ownership

Funds ownership: 35.25% → 35.17% (-0.09%)

5% less funds holding

Funds holding: 79 → 75 (-4)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

Holders
75
Holders Change
-4
Holders Change %
-5.06%
% of All Funds
1.08%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
8
Increased
32
Reduced
26
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SCM
Saba Capital Management
New York
+$13.1M
2
SIA
Sit Investment Associates
Minnesota
+$2.61M
3
AW
Atlas Wealth
Ohio
+$1.13M
4
KIM
Karpus Investment Management
New York
+$796K
5
BBPWM
Blue Bell Private Wealth Management
Pennsylvania
+$416K

Top Sellers

1
Lazard Asset Management
Lazard Asset Management
New York
-$2.51M
2
Allspring Global Investments
Allspring Global Investments
North Carolina
-$1.15M
3
RL
RPO LLC
Connecticut
-$1.07M
4
1CP
1607 Capital Partners
Virginia
-$840K
5
Osaic Holdings
Osaic Holdings
Arizona
-$827K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Saba Capital Management
New York
$48.6M +$13.1M +967,844 +39%
AIA
2
Absolute Investment Advisers
Florida
$7.98M -$476K -35,189 -6%
Morgan Stanley
3
Morgan Stanley
New York
$6.95M +$80.6K +5,962 +1%
1CP
4
1607 Capital Partners
Virginia
$5.94M -$840K -62,100 -13%
KIM
5
Karpus Investment Management
New York
$5.73M +$796K +58,866 +17%
Allspring Global Investments
6
Allspring Global Investments
North Carolina
$4.91M -$1.15M -84,699 -20%
NIM
7
Needham Investment Management
New York
$4.84M +$157K +11,586 +4%
AA
8
AQR Arbitrage
Connecticut
$4.78M -$678K -50,110 -13%
FHA
9
Flagship Harbor Advisors
Massachusetts
$4.28M +$250K +18,511 +7%
RL
10
RPO LLC
Connecticut
$3.67M -$1.07M -79,267 -23%
Bank of America
11
Bank of America
North Carolina
$3.08M -$258K -19,089 -8%
QL
12
Quarry LP
New York
$2.91M -$258K -19,081 -8%
SIA
13
Sit Investment Associates
Minnesota
$2.73M +$2.61M +192,644 New
RJFSA
14
Raymond James Financial Services Advisors
Florida
$2.29M +$48.7K +3,598 +2%
Cetera Investment Advisers
15
Cetera Investment Advisers
Illinois
$2.22M +$137K +10,137 +7%
LPL Financial
16
LPL Financial
California
$2.21M +$64.6K +4,774 +3%
AAM
17
Advisors Asset Management
Colorado
$2.2M +$86.1K +6,365 +4%
Ameriprise
18
Ameriprise
Minnesota
$2.18M +$50.8K +3,757 +3%
1WA
19
180 Wealth Advisors
Washington
$2.01M +$49.8K +3,682 +3%
BFM
20
Boothbay Fund Management
New York
$1.65M -$482K -35,670 -23%
Janney Montgomery Scott
21
Janney Montgomery Scott
Pennsylvania
$1.29M +$64.3K +4,757 +6%
AW
22
Atlas Wealth
Ohio
$1.19M +$1.13M +83,322 New
CCP
23
Clough Capital Partners
Massachusetts
$1.06M -$609K -45,011 -38%
QC
24
Quantedge Capital
Singapore
$899K -$293K -21,700 -25%
BBPWM
25
Blue Bell Private Wealth Management
Pennsylvania
$882K +$416K +30,750 +98%
1
2 3 4

HQL Hedge Fund Activity: Q2 2024 in Review

75 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q2 2024, worth a combined $136M — up 8.3% from $126M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of HQL and 8 opened new positions — a net loss of 2 holders — while 26 trimmed existing stakes and 32 added.

The largest buyer was Saba Capital Management, adding an estimated $13.1M. The largest seller was Lazard Asset Management, exiting entirely with an estimated $2.51M sold.

  • 75 institutional investors held abrdn Life Sciences Investors (HQL) as of Q2 2024, down from 79 in Q1 2024.
  • Funds reported $136M of abrdn Life Sciences Investors stock for Q2 2024, up 8.3% quarter-over-quarter.
  • 8 funds opened new abrdn Life Sciences Investors positions in Q2 2024 and 10 closed out, a net change of -2 holders.
  • The largest abrdn Life Sciences Investors buyer in Q2 2024 was Saba Capital Management, an estimated $13.1M added.
  • The largest abrdn Life Sciences Investors seller in Q2 2024 was Lazard Asset Management, an estimated $2.51M sold.

Based on aggregated 13F filings for Q2 2024.